位置:首页 > 蛋白库 > MAPK2_RABIT
MAPK2_RABIT
ID   MAPK2_RABIT             Reviewed;         366 AA.
AC   P49139; G1T708;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   25-JAN-2012, sequence version 2.
DT   03-AUG-2022, entry version 122.
DE   RecName: Full=MAP kinase-activated protein kinase 2;
DE            Short=MAPK-activated protein kinase 2;
DE            Short=MAPKAP kinase 2;
DE            Short=MAPKAP-K2;
DE            Short=MAPKAPK-2;
DE            Short=MK-2;
DE            Short=MK2;
DE            EC=2.7.11.1;
DE   Flags: Fragment;
GN   Name=MAPKAPK2;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Thorbecke;
RG   The Genome Sequencing Platform;
RA   Di Palma F., Heiman D., Young S., Gnerre S., Johnson J., Lander E.S.,
RA   Lindblad-Toh K.;
RT   "Genome Sequence of Oryctolagus cuniculus (European rabbit).";
RL   Submitted (AUG-2009) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-256.
RC   STRAIN=New Zealand white; TISSUE=Skeletal muscle;
RX   PubMed=8280084; DOI=10.1042/bj2960843;
RA   Stokoe D., Caudwell B., Cohen P.T.W., Cohen P.;
RT   "The substrate specificity and structure of mitogen-activated protein (MAP)
RT   kinase-activated protein kinase-2.";
RL   Biochem. J. 296:843-849(1993).
RN   [3]
RP   FUNCTION IN PHOSPHORYLATION OF HSPB1.
RX   PubMed=1332886; DOI=10.1016/0014-5793(92)81216-9;
RA   Stokoe D., Engel K., Campbell D.G., Cohen P., Gaestel M.;
RT   "Identification of MAPKAP kinase 2 as a major enzyme responsible for the
RT   phosphorylation of the small mammalian heat shock proteins.";
RL   FEBS Lett. 313:307-313(1992).
RN   [4]
RP   PARTIAL PROTEIN SEQUENCE, FUNCTION, AND PHOSPHORYLATION AT THR-300.
RC   STRAIN=New Zealand white;
RX   PubMed=1327754; DOI=10.1002/j.1460-2075.1992.tb05492.x;
RA   Stokoe D., Campbell D.G., Nakielny S., Hidaka H., Leevers S.J.,
RA   Marshall C., Cohen P.;
RT   "MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated
RT   protein kinase.";
RL   EMBO J. 11:3985-3994(1992).
CC   -!- FUNCTION: Stress-activated serine/threonine-protein kinase involved in
CC       cytokine production, endocytosis, reorganization of the cytoskeleton,
CC       cell migration, cell cycle control, chromatin remodeling, DNA damage
CC       response and transcriptional regulation. Following stress, it is
CC       phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to
CC       phosphorylation of substrates. Phosphorylates serine in the peptide
CC       sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue.
CC       Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0,
CC       HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1,
CC       RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the
CC       interaction with HSP90 proteins and inhibiting HSF1 homotrimerization,
CC       DNA-binding and transactivation activities (By similarity). Mediates
CC       phosphorylation of HSP27/HSPB1 in response to stress, leading to
CC       dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps)
CC       oligomers and impairment of their chaperone activities and ability to
CC       protect against oxidative stress effectively. Involved in inflammatory
CC       response by regulating tumor necrosis factor (TNF) and IL6 production
CC       post-transcriptionally: acts by phosphorylating AU-rich elements
CC       (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading
CC       to regulate the stability and translation of TNF and IL6 mRNAs.
CC       Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of
CC       TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA
CC       affinity leading to inhibition of dependent degradation of ARE-
CC       containing transcripts. Phosphorylates CEP131 in response to cellular
CC       stress following ultraviolet irradiation which promotes binding of
CC       CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar
CC       satellites (By similarity). Also involved in late G2/M checkpoint
CC       following DNA damage through a process of post-transcriptional mRNA
CC       stabilization: following DNA damage, relocalizes from nucleus to
CC       cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilization
CC       of GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR)
CC       in dendritic cells: required for acute TLR-induced macropinocytosis by
CC       phosphorylating and activating RPS6KA3. {ECO:0000250|UniProtKB:P49137,
CC       ECO:0000269|PubMed:1327754, ECO:0000269|PubMed:1332886}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Activated following phosphorylation by p38-
CC       alpha/MAPK14 following various stresses. Inhibited following
CC       sumoylation. Specifically inhibited by pyrrolopyridine inhibitors (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer with p38-alpha/MAPK14; this heterodimer forms a
CC       stable complex: molecules are positioned 'face to face' so that the
CC       ATP-binding sites of both kinases are at the heterodimer interface.
CC       Interacts with PHC2. Interacts with HSF1.
CC       {ECO:0000250|UniProtKB:P49137}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P49137}. Nucleus
CC       {ECO:0000250|UniProtKB:P49137}. Note=Phosphorylation and subsequent
CC       activation releases the autoinhibitory helix, resulting in the export
CC       from the nucleus into the cytoplasm. {ECO:0000250|UniProtKB:P49137}.
CC   -!- PTM: Sumoylation inhibits the protein kinase activity.
CC       {ECO:0000250|UniProtKB:P49137}.
CC   -!- PTM: Phosphorylated and activated by MAP kinase p38-alpha/MAPK14 at
CC       Thr-188, Ser-238 and Thr-300. {ECO:0000305|PubMed:1327754}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X75345; CAA53093.1; -; mRNA.
DR   EMBL; AAGW02025411; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; S39794; S39794.
DR   AlphaFoldDB; P49139; -.
DR   BMRB; P49139; -.
DR   SMR; P49139; -.
DR   STRING; 9986.ENSOCUP00000012250; -.
DR   iPTMnet; P49139; -.
DR   eggNOG; KOG0604; Eukaryota.
DR   InParanoid; P49139; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0070935; P:3'-UTR-mediated mRNA stabilization; ISS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; ISS:UniProtKB.
DR   GO; GO:0044351; P:macropinocytosis; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0032675; P:regulation of interleukin-6 production; ISS:UniProtKB.
DR   GO; GO:0032680; P:regulation of tumor necrosis factor production; ISS:UniProtKB.
DR   GO; GO:0034097; P:response to cytokine; ISS:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; ISS:UniProtKB.
DR   Gene3D; 4.10.1170.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR027442; MAPKAPK_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cytoplasm; Direct protein sequencing; DNA damage;
KW   Isopeptide bond; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN           <1..366
FT                   /note="MAP kinase-activated protein kinase 2"
FT                   /id="PRO_0000086290"
FT   DOMAIN          30..291
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          294..330
FT                   /note="Autoinhibitory helix"
FT                   /evidence="ECO:0000250"
FT   REGION          332..356
FT                   /note="p38 MAPK-binding site"
FT                   /evidence="ECO:0000250"
FT   MOTIF           322..331
FT                   /note="Nuclear export signal (NES)"
FT                   /evidence="ECO:0000250"
FT   MOTIF           337..340
FT                   /note="Bipartite nuclear localization signal 1"
FT                   /evidence="ECO:0000250"
FT   MOTIF           351..355
FT                   /note="Bipartite nuclear localization signal 2"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        152
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         36..44
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         59
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         105..107
FT                   /ligand="staurosporine"
FT                   /ligand_id="ChEBI:CHEBI:57491"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         188
FT                   /note="Phosphothreonine; by MAPK14"
FT                   /evidence="ECO:0000250|UniProtKB:P49137"
FT   MOD_RES         238
FT                   /note="Phosphoserine; by MAPK14"
FT                   /evidence="ECO:0000250|UniProtKB:P49137"
FT   MOD_RES         294
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         300
FT                   /note="Phosphothreonine; by MAPK14"
FT                   /evidence="ECO:0000269|PubMed:1327754"
FT   CROSSLNK        319
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        111
FT                   /note="E -> L (in Ref. 2; CAA53093)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        315
FT                   /note="W -> G (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   NON_TER         1
SQ   SEQUENCE   366 AA;  42124 MW;  F1F86EDE08C42C34 CRC64;
     PPPPPPQQFP QFHVRSGLQI KKNAIIDDYK VTSQVLGLGI NGKVLQIFSK KTQEKFALKM
     LQDCPKARRE VELHWRASQC PHIVRIVDVY ENLYAGRKCL LIVMECLDGG ELFSRIQDRG
     DQAFTEREAS EIMKSIGEAI QYLHSINIAH RDVKPENLLY TSKRPKAILK LTDFGFAKET
     TSHNSLTTPC YTPYYVAPEV LGPEKYDKSC DMWSLGVIMY ILLCGYPPFY SNHGLAISPG
     MKTRIRMGQY EFPNPEWSEV SEEVKMLIRN LLKTEPTQRM TITEFMNHPW IMQSTKVPQT
     PLHTSRVLKE DKERWEDVKE EMTSALATMR VDYEQIKIKK IEDASNPLLL KRRKKARALE
     AAALAH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025